title: [Basedow's disease and interferon for hepatitis C. Recurrence as Basedow's ophthalmopathy after interferon reintroduction].
authors.forename: D
authors.initials: D
authors.lastname: Huet
authors.forename: A
authors.initials: A
authors.lastname: Entremont
authors.forename: M
authors.initials: M
authors.lastname: Hautecouverture
mesh_terms: D000893:Anti-Inflammatory Agents / Q000008:administration & dosage; D013956:Antithyroid Agents / Q000627:therapeutic use; D000998:Antiviral Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015551:Autoimmunity; D002231:Carbimazole / Q000627:therapeutic use; D006111:Graves Disease / Q000139:chemically induced* / Q000188:drug therapy / Q000276:immunology; D019698:Hepatitis C, Chronic / Q000175:diagnosis / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008775:Methylprednisolone / Q000008:administration & dosage; D008875:Middle Aged; D012008:Recurrence; D013997:Time Factors
chemical_list: D000893:Anti-Inflammatory Agents; D013956:Antithyroid Agents; D000998:Antiviral Agents; D016898:Interferon-alpha; D002231:Carbimazole; D008775:Methylprednisolone